Skip to Content

Doribax Approval History

  • FDA approved: Yes (First approved October 12th, 2007)
  • Brand name: Doribax
  • Generic name: doripenem
  • Dosage form: Injection
  • Previous name: Doripenem
  • Company: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
  • Treatment for: Intraabdominal Infection, Urinary Tract Infection

Doribax (doripenem) is a penem antibacterial indicated for the treatment of complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis.

Development History and FDA Approval Process for Doribax

Oct 15, 2007Approval FDA Approves Doribax for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Jun  6, 2007New Drug Application Submitted for Investigational Antibiotic Doripenem
Dec 15, 2006New Drug Application Submitted for Investigational Antibiotic Doripenem

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.